Oasis singer sued over love child

Former Oasis frontman Liam Gallgher is being sued for US$3 million by an American journalist who claims he fathered a child with her. Rumours have been swirling in the UK after it was revealed an unnamed rock star was caught in a desperate battle to stop his wife learning about his love child

Share

Apple signs deal with Warner – sources

Apple has signed an agreement with Warner Music Group for music licenses in a push to create a streaming music service to unveil at a conference of its developers next week, the New York Times and Wall Street Journal report, citing anonymous sources. The iPhone maker has been considering a music-streaming service to complement iTunes, the largest repository of music for sale, for the past year, but progress has been slow in hashing out deals with music companies, sources said earlier

Share

One Giant Step For Mankind

The region of Ethiopia called the Middle Awash, some 140 miles northeast of the capital of Addis Ababa, is a hot, harsh and inhospitable place–a rocky desert punctuated by tree-lined rivers, the occasional lake and patches of lava that are slowly being buried by sediments flushed out of the hills by the torrential rains that come along twice a year. But between 5 million and 6 million years ago, the landscape here was very different.

Share

School Head-Lice Policies Must Be Relaxed, Say Doctors

They are miniscule, measuring at most 2 mm to 3 mm long, yet few things induce more panic or fear among parents than head lice. But while an infestation of head lice on a child can be uncomfortable, the critters do not pose enough of a contagious hazard to justify the strict policies that many schools use to keep infected children out of class, according to a new report from the American Academy of Pediatrics

Share

Avandia Approval: FDA’s Drug-Safety Protection in Doubt

Five days before a 2007 article in the New England Journal of Medicine showed that the diabetes drug Avandia was linked to a 43% increase in heart attacks compared with other medications or placebos, a group of scientists and executives from the drug’s maker, GlaxoSmithKline , gathered in a conference room at the offices of the Food and Drug Administration in White Oak, Md. The GSK goal: to convince regulators that the evidence that the company’s $3 billion-a-year blockbuster drug caused heart problems was inconclusive.

Share